Back to Results
First PageMeta Content
Multiple myeloma / Lenalidomide / Dexamethasone / Creatinine / Cyclophosphamide / Plasma cell leukemia / Medicine / Chemistry / Organic chemistry


Phase 2 Trial of Lenalidomide, Cyclophosphamide, And Dexamethasone (CRd) For Newly Diagnosed Myeloma Shaji K. Kumar, Suzanne R. Hayman, Francis K. Buadi, Martha Q. Lacy, Philip R. Greipp, Stephen J. Russell, Steven R. Ze
Add to Reading List

Document Date: 2012-04-18 11:56:14

Open Document

File Size: 431,22 KB

Share Result on Facebook

City

Rochester / /

Facility

Minnesota Mayo Clinic College of Medicine Mayo Clinic Comprehensive Cancer Center Jacksonville / /

IndustryTerm

Treatment protocol / /

MedicalCondition

Uncontrolled infection / multiple myeloma / disease / evaluable disease / /

MedicalTreatment

Treatment protocol / /

Organization

Minnesota Mayo Clinic College of Medicine Mayo Clinic Comprehensive Cancer Center Jacksonville / New York Heart Association / /

Person

S. Vincent Rajkumar / Steven R. Zeldenrust / Rafael Fonseca / Francis K. Buadi / Martha Q. Lacy / Thomas E. Witzig / Suzanne R. Hayman / Keith Stewart / Robert A. Kyle / Tammy S. McCarty / Angela Dispenzieri Scottsdale / Megan Campbell / Stephen J. Russell / Morie A. Gertz / John A. Lust / Leif Bergsagel / Philip R. Greipp / Jake Allred / /

Product

Beta / Revlimid / Dexamethasone / Cyclophosphamide / /

Technology

Treatment protocol / /

SocialTag